GlaxoSmithKline S.A.E. (BIOC.CA)

Also known as:  GSK Egypt, GlaxoSmithKline Egypt
Data delayed by 15 minutes
17.11 EGP 0.000.00%
As of 09 AUG 2020 - GMT|Egypt SE

GSK Egypt Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
-
P/E (Last 12 Month)
8.314
Upside
-
Target Price (Mean)
-
52Wk
5.77 18 MAR
18.4 08 JUL

Open
Data not available
Previous Close
17.11 EGP
Turnover
Data not available
EPS
2.195 EGP
Volume
0
Transactions
0
Market Cap
1.43B EGP
IPO Date
01-Sep-1993
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About GlaxoSmithKline S.A.E.Last updated on: 15 January 2018

Business Summary
Manufacture of branded and generic drugs, chemicals, veterinary, vitamins and nutritional products, pharmaceutical and bulk drugs substance.
Country of Incorporation
Ownership Type
Established In
1981
Primary Sector
Number of Employees
1000
Stock Listing
IDStock TypeCurrencyExchangeSymbol
BIOC.CASEOrdinaryEGPEgypt SEBIOC

Contact details

Primary address
Boomerang Building 46, Block J
Ninety Street
1st-3rd Floor
5th Settlement
41
Egypt
Cairo
11835
CONTACT
  • Tel: +20 2-2618-5000
  • Fax: +20 2-2618-5001
Region
Cairo
More

Takeda celebrates anniversary with brand-new address

The new Area offices based at One Central at Dubai World Trade Centre is recognized for its green credentials, achieving Gold level certification by LEED standards, with Takeda's offices receiving Silver level certification

Press Release - Sunday 9 August 2020
All Health Care News
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

Dr Amro Mohammed Mamdouh Abdulmajid
Managing Director
Dr Ashraf Mohammed Ibrahim Mansour
Medical and Regulatory Director
Mr Amro Abou Naja
Marketing Director

Board Members

Dr Amro Mohammed Mamdouh Abdulmajid
Chairman and director representing GlaxoSmithkline Plc
Dr Ashraf Mohammed Ibrahim Mansour
Director director representing GlaxoSmithkline Plc
Mr Jude Albert Brajanza
Director representing GlaxoSmithkline Plc
More

Company information provided by Refinitiv

Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
ADVANCED PHARMA2.330 EGP0.00
EGYPT INTL PHRM49.000 EGP0.00
ARAB PHARM63.990 EGP0.00
ALX. PHARMACEUT.135.380 EGP0.00
CLEOPATRA HOSP4.970 EGP0.00
MEDICAL PACK1.965 EGP0.00
More

Monday Outlook: Asian stocks cautious; dollar holds gains

Monday Outlook: Asian stocks cautious; dollar holds gains

Gold steady on virus fears; oil on the rise on U.S. stimulus hopes

More

Most Viewed Stocks

Stock Screener

More